I included the correspondences between I and Peregrine Pharmaceuticals, and welcome feedback. Pls pray and fast that Herpes 2 will have a chance to be under clinical trial with Tarvacin or even a miracle to switch Hepatitis C with Herpes 2----a divine intervention. Pls fast for one day if necessary. I never fast before. However, yesterday at 11:00p, a Christian brother checked on me. I replied that I had no outbreak thur'out the day. He told me he had fasted his lunch and prayed for me. Amazing, due to his love, fast and prayer, I have one day no outbreak.
Below are the correspondences:
Dear Frank, 6/14/05
Thank you very much for our phone conversation on 5/13/05 regarding whether IND filed for Tarvacin can be switched for clinical trial on Herpes 2 instead of Hep C. You and I had concluded that if I gather some names and you can help me to forward to related persons that there are some voices wishing Herpes 2 can be in clinical trial instead. As of now, I had 4 people interested to undergo clinical trial with Tarvacin, and as follows:
Before I continue to gather volunteers with Herpes 2 to undergo clinical trial, I want to back off with a questions. Does the success of Tarvacin in treating Hep. C meant the same as success of tarvacin in treating Herpes 2? Both Hep. C and Herpes 2 are enveloped viruses. If yes, I don't need to ask for volunteers. If not, is your company still interested in clinical trial with Herpes 2 in the near future? And does your company has sufficient fundings for clinical trial with Herpes 2 along with Hep. C?
I am ready to ask for donations from computer companies, semiconductor companies, international Herpes society, etc. for donations if there is insufficeint fundings from Peregrine Pharmaceuticals.
In the meantime, I will still gather volunteers.
Thank you in advance for giving us hope admist our adversity, and wish you everything the best,
Frank is currently out of office, but I have a response from the company. The company currently has approval to move ahead on a Hep C trial only at the present time, however, we plan to broaden to other indications in the future. Pls stay in touch with the company via email and watch out website for new annoucement.